NASDAQ:GALT

Galectin Therapeutics Stock Forecast

etoro logo Buy GALT
*Your capital is at risk
$6.00
+0.490 (+8.89%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of GALT
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Strong day for Galectin Therapeutics Inc. stock price on Monday rising 8.89% to $6.00
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 07, 2025 Gain 25.79%

The Galectin Therapeutics Inc. stock price gained 8.89% on the last trading day (Monday, 17th Nov 2025), rising from $5.51 to $6.00. During the last trading day the stock fluctuated 8.73% from a day low at $5.61 to a day high of $6.10. The price has fallen in 6 of the last 10 days. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 226 thousand more shares were traded than the day before. In total, 465 thousand shares were bought and sold for approximately $2.79 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $6.24 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 32.21% during the next 3 months and, with a 90% probability hold a price between $6.56 and $8.25 at the end of this 3-month period.

GALT Signals & Forecast

The Galectin Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.54 and $5.12. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, November 03, 2025, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

Galectin Therapeutics Inc. finds support from accumulated volume at $5.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.490 between high and low, or 8.73%. For the last week, the stock has had daily average volatility of 9.49%.

Our recommended stop-loss: $5.78 (-3.74%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (GALT) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Galectin Therapeutics Inc. to open at $5.90, and during the day (based on 14 day Average True Range), to move between $5.77 and $6.23, which gives a possible trading interval of +/-$0.458 (+/-7.93%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.93% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $5.94, some $0.0600 (1.00%) from the current price of $6.00, our system finds the risk reward attractive.

Is Galectin Therapeutics Inc. stock A Buy?

Galectin Therapeutics Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.509 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $5.90 ( 1.61%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

GALT Performance

Trading levels for GALT

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.39 6.56%
R2 6.21 3.44%
R1 6.09 1.51%
Price 6.00
S1 5.72 -4.73%
S2 5.60 -6.66%
S3 5.41 -9.78%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 6.00
S1 5.94 -1.00%
S2 5.37 -10.50%
S3 5.20 -13.33%

FAQ

What is the symbol for Galectin Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Galectin Therapeutics Inc. is GALT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galectin Therapeutics Inc. Stock?
Galectin Therapeutics Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Galectin Therapeutics Inc. Stock?
Galectin Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galectin Therapeutics Inc. Stock.

What's the current price of Galectin Therapeutics Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Galectin Therapeutics Inc. (GALT) share was $6.00.

What is the 52-week high and low for Galectin Therapeutics Inc. Stock?
The 52-week high for Galectin Therapeutics Inc. Stock is $6.55 and the 52-week low is $0.726.

What is the market capitalization of Galectin Therapeutics Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Galectin Therapeutics Inc. is 386.313M.

When is the next earnings date for Galectin Therapeutics Inc.?
The upcoming earnings date for Galectin Therapeutics Inc. is May 13, 2026.
Click to get the best stock tips daily for free!
ABOUT GALECTIN THERAPEUTICS INC.
Galectin Therapeutics
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE